- Home
- LENZ vs DPG Comparison
LENZ vs DPG Comparison
Compare LENZ & DPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$8.29
Company Overview
Basic Information| Metric | LENZ | DPG |
|---|---|---|
| Founded | 2019 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 609.5M | 535.3M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | LENZ | DPG |
|---|---|---|
| Price | $8.29 | $14.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.60 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 83.0K |
| Earning Date | 03-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,088,000.00 | N/A |
| Revenue This Year | $162.79 | N/A |
| Revenue Next Year | $170.32 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.40 | $10.45 |
| 52 Week High | $50.19 | $14.96 |
Technical Indicators
Market Signals| Indicator | LENZ | DPG |
|---|---|---|
| Relative Strength Index (RSI) | 27.19 | 51.64 |
| Support Level | N/A | $14.04 |
| Resistance Level | $12.70 | $14.81 |
| Average True Range (ATR) | 0.83 | 0.25 |
| MACD | -0.23 | -0.03 |
| Stochastic Oscillator | 0.45 | 44.23 |
Price Performance
Historical Comparison LENZ
DPG
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About DPG Duff & Phelps Utility and Infrastructure Fund Inc.
Duff & Phelps Utility & Infrastructure Fund Inc. is an investment fund, and its objective is to seek total return, derived mainly from a high level of current income, with an emphasis on providing tax-advantaged dividend income and growth in current income, and secondarily from capital appreciation.